Market Overview

Earnings Recap For March 14

Share:

3D Systems Corporation (NYSE: DDD) reported earnings of $0.19 per share, $0.11 above the Street’s consensus. Revenue of $183.36 million also came in ahead of expectations for $182.88 million.

Black Diamond Inc (NASDAQ: BDE) posted earnings of $0.02 per share, $0.03 ahead of the Street’s consensus. Revenue of $44.1 million also beat estimates by $5.21 million, even though it fell 25.8 percent year-over-year.

Jamba, Inc. (NASDAQ: JMBA) delivered a net loss of $(0.28) per share, $0.21 worse than what the Street expected. Revenue of $19.55 million, down 55.5 percent year-over-year, however, came in $1.45 million above estimates.

Inter Parfums, Inc. (NASDAQ: IPAR) retrieved earnings of $0.06 per share, falling $0.01 short of the Street’s consensus. Revenue of $118.33 million was in line with expectations.

TravelCenters of America LLC (NYSE: TA) reported a net loss of $(0.04) per share; the Street, however, was expecting earnings of $0.02 per share. Revenue of $1.351 billion also missed estimates of $1.523 billion.

Ply Gem Holdings Inc (NYSE: PGEM) posted earnings of $0.13 per share, beating the Street’s consensus by $0.09. Revenue of $430.46 million, nonetheless, came in below expectations for $467.11 million.

Solazyme Inc (NASDAQ: SZYM) delivered a net loss of $(0.43) per share, missing the Street’s consensus by $0.12. Revenue of $10.39 million also came in well below expectations for $19.1 million.

Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.

Posted-In: Earnings News After-Hours Center

 

Related Articles (DDD + BDE)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Jim Strugger's SPDR Gold Trust (ETF) Trade

Immunomedics Offers Update on Phase 3 PANCRIT-1 Trial of Clivatuzumab Tetraxetan in Patients with Advanced Pancreatic Cancer